Clinical trial
Therapeutic Efficacy and Safety of Non-Invasive Radiofrequency Treatment in Patients With Refractory Meibomian Gland Dysfunction: A Randomized Controlled Trial
NCT06220474 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Therapeutic Efficacy and Safety of Non-Invasive Radiofrequency Treatment in Patients With Refractory Meibomian Gland Dysfunction: A Randomized Controlled Trial
- Lead sponsor
- The University of Hong Kong
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 22, 2024
- Completion date
- December 31, 2027
- Enrollment
- 112 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.